A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

a study on Inflammatory Bowel Disease

Summary

Eligibility
for females ages 18-45 (full criteria)
Location
at San Francisco, California and other locations
Dates
start:
end: about
Principal Investigator
by Uma Mahadevan, MD
Headshot of Uma Mahadevan
Uma Mahadevan

Description

Summary

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.

Details

All pregnant women with IBD diagnosis who are taking biologics medicines and immunosuppressants will be entered in the study.

Keywords

Inflammatory Bowel Disease, pregnant IBD patients, Intestinal Diseases, Inflammatory Bowel Diseases

Eligibility

You can join if…

Open to females ages 18-45

- Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy

You CAN'T join if...

  • Pregnant female patients younger than 18 years of age
  • Confirmed multiple gestation

Locations

  • UCSF accepting new patients
    San Francisco California 94115 United States
  • Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations accepting new patients
    San Francisco California 94115 United States

Lead Scientist at UCSF

  • Uma Mahadevan, MD
    Dr. Mahadevan completed a medical degree at the State University of New York in Brooklyn. She completed residency in internal medicine at Mount Sinai Medical Center in New York, a fellowship in gastroenterology at the University of California, San Francisco (UCSF) and a fellowship in inflammatory bowel disease (IBD) at the Mayo Clinic in Rochester, Minnesota.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT00904878
Study Type
Observational
Participants
Expecting 1500 study participants
Last Updated
Contact us about this trial